Inner Mongolia Furui Medical Science Co., Ltd.

XSEC:300049 Stock Report

Market Cap: CN¥11.4b

Inner Mongolia Furui Medical Science Future Growth

Future criteria checks 5/6

Inner Mongolia Furui Medical Science is forecast to grow earnings and revenue by 43.5% and 30.6% per annum respectively. EPS is expected to grow by 43.9% per annum. Return on equity is forecast to be 18.5% in 3 years.

Key information

43.5%

Earnings growth rate

43.9%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate30.6%
Future return on equity18.5%
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300049 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,7714303126333
12/31/20252,1593071104534
12/31/20241,584203-102154
6/30/20241,27213385289N/A
3/31/20241,23413190273N/A
12/31/20231,154102116305N/A
9/30/20231,09711099282N/A
6/30/20231,084109148268N/A
3/31/20231,042102109223N/A
1/1/20231,0099899189N/A
9/30/20221,01798120197N/A
6/30/20229608690174N/A
3/31/202293192134221N/A
1/1/202289895143223N/A
9/30/202184890125220N/A
6/30/20218328983201N/A
3/31/20217806460169N/A
12/31/20208086290200N/A
9/30/20208175079171N/A
6/30/202080842144210N/A
3/31/202086247213278N/A
12/31/201983243190256N/A
9/30/20198581176269N/A
6/30/2019865393178N/A
3/31/20198663224122N/A
12/31/201886735-1678N/A
9/30/2018824712384N/A
6/30/20187997080138N/A
3/31/201884463N/A138N/A
12/31/201782361N/A132N/A
9/30/2017882117N/A106N/A
6/30/2017886117N/A109N/A
3/31/2017858121N/A114N/A
12/31/2016827121N/A149N/A
9/30/2016709100N/A189N/A
6/30/201667199N/A143N/A
3/31/201660892N/A167N/A
12/31/201560492N/A158N/A
9/30/201564990N/A101N/A
6/30/2015668108N/A127N/A
3/31/201563490N/A72N/A
12/31/201464687N/A51N/A
9/30/201456739N/A23N/A
6/30/201456415N/A36N/A
3/31/20145337N/A27N/A
12/31/20135235N/A28N/A
9/30/20135166N/A25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300049's forecast earnings growth (43.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 300049's earnings (43.5% per year) are forecast to grow faster than the CN market (23% per year).

High Growth Earnings: 300049's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300049's revenue (30.6% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 300049's revenue (30.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300049's Return on Equity is forecast to be low in 3 years time (18.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y